Better cardiovascular safety and lower risk of all-cause mortality was observed among older adult patients with IBD who received ustekinumab vs vedolizumab.

Clinical trials help researchers studying chronic conditions answer important questions about the diseases and their treatment options. However, uncertainty about what to expect and a lack of ...

To present the pioneering concept, Peer and his team encoded the anti-inflammatory protein interleukin-10 into mRNA and ...

INDIANAPOLIS - Eli Lilly and Company (NYSE: NYSE:LLY), a pharmaceutical giant with a market capitalization of $783.7 billion ...

Low-fiber fruits and vegetables, lean proteins, and foods rich in omega-3 fatty acids tend to be easier on an inflamed gut, ...

Omvoh has additional ongoing trials in Crohn's disease and UC, including studies to evaluate the long-term efficacy and safety of Omvoh in pediatric patients and adults, and a Phase 4 real-world ...

The composite of patient-reported clinical response and endoscopic response was significantly greater in mirikizumab versus ...

Resilience has characterized many people who have dealt with chronic health challenges, and it would be hard to find someone ...

A colorectal surgeon named Dr Cedrek McFadden has shared the top five reasons why people may be at risk of getting colorectal ...

A doctor and medical advisor has shared the top five factors that could increase people's risk at getting colorectal cancer, and what to do to prevent it as 54% of bowel cancer cases are preventable ...